MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Immune Design Corp Company Profile (NASDAQ:IMDZ)

Consensus Ratings for Immune Design Corp (NASDAQ:IMDZ) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $31.50 (288.41% upside)

Analysts' Ratings History for Immune Design Corp (NASDAQ:IMDZ)
Show:
DateFirmActionRatingPrice TargetActions
10/15/2015Jefferies GroupReiterated RatingBuy$30.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/8/2015Jefferies GroupInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015Leerink SwannInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Jefferies GroupReiterated RatingBuy$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015Jefferies GroupUpgradeHold -> Buy$32.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014Jefferies GroupDowngradeBuy -> Hold$15.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Jefferies GroupInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha